Ayse Leyla Mindikoglu, M.D., M.P.H.

Associate Professor of Medicine
Baylor College of Medicine

Position

Associate Professor of Medicine
Margaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology
Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation
Baylor College of Medicine

Address

Baylor Clinic (Clinic)
6620 Main Street
Suite 1450
Houston, Texas 77030
United States
Google Maps

Certifications

Internal Medicine
American Board of Internal Medicine
Gastroenterology
American Board of Internal Medicine
Transplant Hepatology
American Board of Internal Medicine

Education

Fellowship at University of Miami Leonard M. Miller School of Medicine
06/2005 - Miami, Florida United States
Fellowship at Loyola University Medical Center
06/2004 - Maywood, Illinois United States
Residency at Bronx-Lebanon Hospital Center
06/2001 - Bronx, New York United States
Residency at University of Istanbul, Cerrahpasa Faculty of Medicine
Istanbul Turkey
MD from University of Istanbul, Cerrahpasa Faculty of Medicine
07/1995 - Istanbul Turkey
MPH from University of Maryland Baltimore
12/2007 - Baltimore, Maryland United States

Gender

Female

Professional Statement

Dr. Ayse Leyla Mindikoglu is board-certified in Internal Medicine, Gastroenterology, and Transplant Hepatology with over 16 years of experience in academic clinical practice. She is a clinician, educator, and researcher. Dr. Mindikoglu's current research investigates the effect of intermittent fasting from dawn to sunset on human serum proteome and metabolism. Additionally, Dr. Mindikoglu's research has been focused on renal dysfunction and acute kidney injury in cirrhosis, and the development of new biomarkers of glomerular filtration rate in cirrhosis. Supported by the NIH/NIDDK K23 award between 2010 and 2015, and Roderick D. MacDonald Research Award/Baylor St. Luke's Medical Center between 2017 and 2019, Dr. Mindikoglu conducted several clinical studies to understand key concepts of altered renal hemodynamics in cirrhosis and develop metabolomic biomarkers of cirrhosis.

Professional Achievements

2022 Women of Excellence Award
2010 Mentored Patient-Oriented Research Career Development Award (National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases K23)
2004 American Association for the Study of Liver Diseases Advanced Hepatology Fellowship Award
2002 Travel Grant for the 8th Methodologies in Healthcare Outcomes in Gastroenterology Workshop Symposium sponsored by Gastroenterology Research Group (GRG) and the American Gastroenterological Association (AGA)
2002 Third Place Abstract Presentation in Annual Research Prize Competition of the Chicago Society for Gastroenterology
2002 Winner of the Biannual Chicago Academic Debate entitled “Liver Disease: Controversies in the New Millennium”
2021 Roderick D. MacDonald Research Award/Baylor St. Luke’s Medical Center
2020 Roderick D. MacDonald Research Award/Baylor St. Luke’s Medical Center
2019 Roderick D. MacDonald Research Award/Baylor St. Luke’s Medical Center
2017 Roderick D. MacDonald Research Award/Baylor St. Luke’s Medical Center
2019 Fellow, American Association for the Study of Liver Diseases
2017 Faculty Research Award, Baylor College of Medicine, Michael E. DeBakey Department of Surgery (Dr. Mindikoglu declined this award due to an another successful overlapping award)
2017 Poster of Distinction at Digestive Disease Week®, Chicago, IL
2011 Presidential Poster of Distinction at the Liver Meeting 2011 of the American Association of the Study for Liver Diseases (AASLD), San Francisco, CA

Professional Interests

Cirrhosis and complications (Ascites, esophageal/gastric varices, gastric antral vascular ectasia, portal hypertensive gastropathy, encephalopathy, hepatocellular carcinoma, hepatorenal syndrome, portopulmonary syndrome, hepatopulmonary syndrome)
Chronic liver diseases (e.g. Fatty liver, hepatitis B, hepatitis C, autoimmune hepatitis, alcoholic hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, Wilson disease, hemochromatosis, drug-induced liver injury)
Acute liver failure
Benign and malignant liver tumors
Liver transplantation (Evaluation for liver transplantation and simultaneous liver- kidney, liver-heart, liver-lung and liver-multiorgan transplantation)
Post-liver transplant management (Acute and chronic liver graft rejection, immunosuppressive medication management, treatment of post-liver transplant recurrent hepatitis and liver disease)
Endoscopy (Esophagogastroduodenoscopy, variceal banding, colonoscopy)
Intermittent fasting
Fatty liver disease